POF1B actin binding protein activators are instrumental in modulating the cytoskeletal architecture of the cell. Certain compounds directly stimulate adenylyl cyclase, leading to an increase in intracellular cAMP levels, setting the stage for the protein's enhanced interaction with the actin cytoskeleton. Others bind to their respective receptors and initiate a cascade of intracellular signaling that culminates in the remodeling of the actin framework, a process in which POF1B plays a critical role. The inhibition of protein phosphatases that ordinarily dephosphorylate cytoskeletal proteins results in a hyperphosphorylated state that may favor the protein's binding to actin. Similarly, stabilizing agents of actin filaments ensure an increase in actin polymerization, which could provide more binding opportunities for POF1B. Additionally, modulating the dynamics of actin and myosin, such as by inhibiting myosin ATPase activity, could indirectly influence the protein's activity by altering the actin-myosin interactions.
On another front, certain ions play a pivotal role in the regulation of actin dynamics, and the introduction of ionophores can result in elevated intracellular calcium levels that activate numerous calcium-binding proteins, impacting POF1B's role. Inhibition of key kinases through specific inhibitors can also result in the stabilization of actin-associated proteins, thereby potentially enhancing the protein's function. Moreover, the use of a cell-permeable cAMP analog further indicates the importance of cAMP-mediated pathways in facilitating the protein's interaction with the actin cytoskeleton.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, which increases cAMP levels in cells, providing an environment for POF1B activation as cAMP signaling can lead to actin cytoskeleton rearrangements. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate various proteins that interact with the actin cytoskeleton thus potentially enhancing POF1B activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Specific inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of cytoskeleton-associated proteins, which could enhance POF1B's role in actin binding. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments and can lead to an increase in actin polymerization, which may enhance POF1B's actin-binding activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium concentration, which could activate calcium-binding proteins that influence actin dynamics, indirectly affecting POF1B activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase 3 (GSK-3), which may result in the stabilization of proteins associated with the actin cytoskeleton, potentially enhancing POF1B's function. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Activates insulin receptor signaling pathways that can lead to actin cytoskeleton remodeling, which may augment POF1B's actin-binding capabilities. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Binds to its receptors, triggering signaling pathways that can lead to cytoskeletal rearrangements, potentially increasing POF1B's functional activity. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Inhibits myosin II ATPase activity, altering the actin-myosin dynamics, which could indirectly result in the activation of POF1B's role in actin binding. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cell-permeable cAMP analog that activates cAMP-dependent pathways, potentially enhancing POF1B's association with the actin cytoskeleton. | ||||||